secwatch.observer — SEC 8-K summary
======================================

Issuer:     Novo Integrated Sciences, Inc. (—)
CIK:        0001138978
Form:       8-K
Filed at:   2025-02-25T23:59:59+00:00
Accession:  0001493152-25-008216
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Novo Integrated Sciences extends CEO resignation date to March 7, 2025; no successor named
--------------------------------------------------------------------------------

- CEO Robert Mattacchione's resignation effective date extended to no later than March 7, 2025.
- Mattacchione will remain as Chairman of the Board and Chairman of Novo Healthnet Limited subsidiary.
- Resignation not due to any disagreement with company on operations, policies, or practices.
- No replacement CEO has been announced; transition ongoing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1138978/000149315225008216/0001493152-25-008216-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1138978/000149315225008216/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-008216

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer